title: Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer.
authors.affiliation: From Cardiovascular Division (N.B., J.A.B., J.M.), Cardio-Oncology Program (N.B., J.M.), Vanderbilt-Ingram Cancer Center (D.F.P., A.K.M., J.M.), and Department of Urologic Surgery (D.F.P., A.K.M.), Vanderbilt University School of Medicine, Nashville, TN; Cardio-Oncology Service, Sirio-Libanes Hospital, Sao Paulo, Brazil (M.S.); Department of Cardiology, Sao Paulo Cancer Institute (ICESP), University of Sao Paulo, Brazil (M.S.); and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (L.W.J.).
authors.forename: Nirmanmoh
authors.initials: N
authors.lastname: Bhatia
authors.affiliation: From Cardiovascular Division (N.B., J.A.B., J.M.), Cardio-Oncology Program (N.B., J.M.), Vanderbilt-Ingram Cancer Center (D.F.P., A.K.M., J.M.), and Department of Urologic Surgery (D.F.P., A.K.M.), Vanderbilt University School of Medicine, Nashville, TN; Cardio-Oncology Service, Sirio-Libanes Hospital, Sao Paulo, Brazil (M.S.); Department of Cardiology, Sao Paulo Cancer Institute (ICESP), University of Sao Paulo, Brazil (M.S.); and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (L.W.J.).
authors.forename: Marilia
authors.initials: M
authors.lastname: Santos
authors.affiliation: From Cardiovascular Division (N.B., J.A.B., J.M.), Cardio-Oncology Program (N.B., J.M.), Vanderbilt-Ingram Cancer Center (D.F.P., A.K.M., J.M.), and Department of Urologic Surgery (D.F.P., A.K.M.), Vanderbilt University School of Medicine, Nashville, TN; Cardio-Oncology Service, Sirio-Libanes Hospital, Sao Paulo, Brazil (M.S.); Department of Cardiology, Sao Paulo Cancer Institute (ICESP), University of Sao Paulo, Brazil (M.S.); and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (L.W.J.).
authors.forename: Lee W
authors.initials: LW
authors.lastname: Jones
authors.affiliation: From Cardiovascular Division (N.B., J.A.B., J.M.), Cardio-Oncology Program (N.B., J.M.), Vanderbilt-Ingram Cancer Center (D.F.P., A.K.M., J.M.), and Department of Urologic Surgery (D.F.P., A.K.M.), Vanderbilt University School of Medicine, Nashville, TN; Cardio-Oncology Service, Sirio-Libanes Hospital, Sao Paulo, Brazil (M.S.); Department of Cardiology, Sao Paulo Cancer Institute (ICESP), University of Sao Paulo, Brazil (M.S.); and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (L.W.J.).
authors.forename: Joshua A
authors.initials: JA
authors.lastname: Beckman
authors.affiliation: From Cardiovascular Division (N.B., J.A.B., J.M.), Cardio-Oncology Program (N.B., J.M.), Vanderbilt-Ingram Cancer Center (D.F.P., A.K.M., J.M.), and Department of Urologic Surgery (D.F.P., A.K.M.), Vanderbilt University School of Medicine, Nashville, TN; Cardio-Oncology Service, Sirio-Libanes Hospital, Sao Paulo, Brazil (M.S.); Department of Cardiology, Sao Paulo Cancer Institute (ICESP), University of Sao Paulo, Brazil (M.S.); and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (L.W.J.).
authors.forename: David F
authors.initials: DF
authors.lastname: Penson
authors.affiliation: From Cardiovascular Division (N.B., J.A.B., J.M.), Cardio-Oncology Program (N.B., J.M.), Vanderbilt-Ingram Cancer Center (D.F.P., A.K.M., J.M.), and Department of Urologic Surgery (D.F.P., A.K.M.), Vanderbilt University School of Medicine, Nashville, TN; Cardio-Oncology Service, Sirio-Libanes Hospital, Sao Paulo, Brazil (M.S.); Department of Cardiology, Sao Paulo Cancer Institute (ICESP), University of Sao Paulo, Brazil (M.S.); and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (L.W.J.). alicia.morgans@vanderbilt.edu javid.moslehi@vanderbilt.edu.
authors.forename: Alicia K
authors.initials: AK
authors.lastname: Morgans
authors.affiliation: From Cardiovascular Division (N.B., J.A.B., J.M.), Cardio-Oncology Program (N.B., J.M.), Vanderbilt-Ingram Cancer Center (D.F.P., A.K.M., J.M.), and Department of Urologic Surgery (D.F.P., A.K.M.), Vanderbilt University School of Medicine, Nashville, TN; Cardio-Oncology Service, Sirio-Libanes Hospital, Sao Paulo, Brazil (M.S.); Department of Cardiology, Sao Paulo Cancer Institute (ICESP), University of Sao Paulo, Brazil (M.S.); and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (L.W.J.). alicia.morgans@vanderbilt.edu javid.moslehi@vanderbilt.edu.
authors.forename: Javid
authors.initials: J
authors.lastname: Moslehi
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D002784:Cholesterol / Q000378:metabolism; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000196:embryology / Q000628:therapy; D015444:Exercise / Q000502:physiology; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D002784:Cholesterol; D001241:Aspirin
references.citation: J Am Heart Assoc. 2015 Apr 20;4(4):null
references.pmid: 25896892
references.citation: Am J Hypertens. 2015 Nov;28(11):1295-302
references.pmid: 25911639
references.citation: Eur J Cancer Prev. 2015 Jul;24(4):335-9
references.pmid: 25075878
references.citation: Circulation. 2010 Feb 16;121(6):833-40
references.pmid: 20124128
references.citation: Circulation. 2014 Oct 28;130(18):e157-9
references.pmid: 25462826
references.citation: Eur Urol. 2014 Mar;65(3):565-73
references.pmid: 24210090
references.citation: Eur Urol. 2015 May;67(5):825-36
references.pmid: 25097095
references.citation: J Natl Cancer Inst. 2012 Sep 5;104(17):1335-42
references.pmid: 22835388
references.citation: Crit Rev Oncol Hematol. 2013 Apr;86(1):42-51
references.pmid: 23092636
references.citation: Eur Urol. 2014 May;65(5):873-4
references.pmid: 24315708
references.citation: J Clin Oncol. 2015 Mar 20;33(9):1078-85
references.pmid: 25667275
references.citation: CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71
references.pmid: 24890451
references.citation: Cancer Causes Control. 2012 Feb;23(2):221-30
references.pmid: 22116540
references.citation: J Clin Oncol. 2014 Nov 20;32(33):3716-22
references.pmid: 25332245
references.citation: Lancet Oncol. 2010 Oct;11(10):914-6
references.pmid: 20708967